The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

3-Hydroxyanthranilic acid     2-amino-3-hydroxy-benzoic acid

Synonyms: PubChem22539, SureCN88229, AGN-PC-00JUO5, CHEMBL445304, CCRIS 4427, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of 3-Hydroxyanthranilic acid


High impact information on 3-Hydroxyanthranilic acid


Chemical compound and disease context of 3-Hydroxyanthranilic acid


Biological context of 3-Hydroxyanthranilic acid


Anatomical context of 3-Hydroxyanthranilic acid


Associations of 3-Hydroxyanthranilic acid with other chemical compounds


Gene context of 3-Hydroxyanthranilic acid


Analytical, diagnostic and therapeutic context of 3-Hydroxyanthranilic acid


  1. Combined purification of actinomycin synthetase I and 3-hydroxyanthranilic acid 4-methyltransferase from Streptomyces antibioticus. Jones, G.H. J. Biol. Chem. (1993) [Pubmed]
  2. Prokaryotic homologs of the eukaryotic 3-hydroxyanthranilate 3,4-dioxygenase and 2-amino-3-carboxymuconate-6-semialdehyde decarboxylase in the 2-nitrobenzoate degradation pathway of Pseudomonas fluorescens strain KU-7. Muraki, T., Taki, M., Hasegawa, Y., Iwaki, H., Lau, P.C. Appl. Environ. Microbiol. (2003) [Pubmed]
  3. A novel degradative pathway of 2-nitrobenzoate via 3-hydroxyanthranilate in Pseudomonas fluorescens strain KU-7. Hasegawa, Y., Muraki, T., Tokuyama, T., Iwaki, H., Tatsuno, M., Lau, P.C. FEMS Microbiol. Lett. (2000) [Pubmed]
  4. Superoxide dismutase enhances the toxicity of 3-hydroxyanthranilic acid to bacteria. Ishii, T., Iwahashi, H., Sugata, R., Kido, R. Free Radic. Res. Commun. (1991) [Pubmed]
  5. Increased levels of serum lipofuscin derived from 3-hydroxyanthranilic acid in patients with chronic renal failure. Hegedus, Z.L., Frank, H.A., Steinman, T.I., Altschule, M.D., Nayak, U. Arch. Int. Physiol. Biochim. (1987) [Pubmed]
  6. Inhibition by interferon-gamma of human mononuclear cell-mediated low density lipoprotein oxidation. Participation of tryptophan metabolism along the kynurenine pathway. Christen, S., Thomas, S.R., Garner, B., Stocker, R. J. Clin. Invest. (1994) [Pubmed]
  7. Molecular cloning and functional expression of human 3-hydroxyanthranilic-acid dioxygenase. Malherbe, P., Köhler, C., Da Prada, M., Lang, G., Kiefer, V., Schwarcz, R., Lahm, H.W., Cesura, A.M. J. Biol. Chem. (1994) [Pubmed]
  8. Pneumococcal meningitis causes accumulation of neurotoxic kynurenine metabolites in brain regions prone to injury. Bellac, C.L., Coimbra, R.S., Christen, S., Leib, S.L. Neurobiol. Dis. (2006) [Pubmed]
  9. Tryptophan metabolism and oxidative stress in patients with Huntington's disease. Stoy, N., Mackay, G.M., Forrest, C.M., Christofides, J., Egerton, M., Stone, T.W., Darlington, L.G. J. Neurochem. (2005) [Pubmed]
  10. Vitamin effects on tryptophan-niacin metabolism in primary hepatoma patients. Hankes, L.V., Schmaeler, M., Jansen, C.R., Brown, R.R. Adv. Exp. Med. Biol. (1999) [Pubmed]
  11. HPLC profiling of Trp-related metabolites in humans. Marklová, E., Albahri, Z., Nozicková, M. Adv. Exp. Med. Biol. (2003) [Pubmed]
  12. 3-Hydroxyanthranilic acid is an efficient, cell-derived co-antioxidant for alpha-tocopherol, inhibiting human low density lipoprotein and plasma lipid peroxidation. Thomas, S.R., Witting, P.K., Stocker, R. J. Biol. Chem. (1996) [Pubmed]
  13. Kynurenines impair energy metabolism in rat cerebral cortex. Schuck, P.F., Tonin, A., da Costa Ferreira, G., Viegas, C.M., Latini, A., Duval Wannmacher, C.M., de Souza Wyse, A.T., Dutra-Filho, C.S., Wajner, M. Cell. Mol. Neurobiol. (2007) [Pubmed]
  14. Comparative study of tumorigenicity in mice administered transplacentally or neonatally with metabolites of tryptophan and its related compounds. Fujii, K., Watanabe, M. J. Cancer Res. Clin. Oncol. (1980) [Pubmed]
  15. Mechanism of delayed increases in kynurenine pathway metabolism in damaged brain regions following transient cerebral ischemia. Saito, K., Nowak, T.S., Markey, S.P., Heyes, M.P. J. Neurochem. (1993) [Pubmed]
  16. Involvement of oxidoreductive reactions of intracellular haemoglobin in the metabolism of 3-hydroxyanthranilic acid in human erythrocytes. Tomoda, A., Shirasawa, E., Nagao, S., Minami, M., Yoneyama, Y. Biochem. J. (1984) [Pubmed]
  17. Promotional effect of lithocholic acid and 3-hydroxyanthranilic acid on transformation of X-ray-initiated BALB/3T3 cells. Umeda, M., Tanaka, K., Ono, T. Carcinogenesis (1989) [Pubmed]
  18. Presence of 3-hydroxyanthranilic acid in rat tissues and evidence for its production from anthranilic acid in the brain. Baran, H., Schwarcz, R. J. Neurochem. (1990) [Pubmed]
  19. Synthesis of quinolinic acid by 3-hydroxyanthranilic acid oxygenase in rat brain tissue in vitro. Foster, A.C., White, R.J., Schwarcz, R. J. Neurochem. (1986) [Pubmed]
  20. Effects of oxygen on 3-hydroxyanthranilate oxidase of the kynurenine pathway. Dang, Y., Xia, C., Brown, O.R. Free Radic. Biol. Med. (1998) [Pubmed]
  21. Different kynurenine pathway enzymes limit quinolinic acid formation by various human cell types. Heyes, M.P., Chen, C.Y., Major, E.O., Saito, K. Biochem. J. (1997) [Pubmed]
  22. 3-Hydroxyanthranilic acid, one of l-tryptophan metabolites, inhibits monocyte chemoattractant protein-1 secretion and vascular cell adhesion molecule-1 expression via heme oxygenase-1 induction in human umbilical vein endothelial cells. Pae, H.O., Oh, G.S., Lee, B.S., Rim, J.S., Kim, Y.M., Chung, H.T. Atherosclerosis (2006) [Pubmed]
  23. Inhibition of nitric oxide synthase expression and activity in macrophages by 3-hydroxyanthranilic acid, a tryptophan metabolite. Sekkaï, D., Guittet, O., Lemaire, G., Tenu, J.P., Lepoivre, M. Arch. Biochem. Biophys. (1997) [Pubmed]
  24. Regulatory role of tryptophan degradation pathway in HLA-G expression by human monocyte-derived dendritic cells. López, A.S., Alegre, E., LeMaoult, J., Carosella, E., González, A. Mol. Immunol. (2006) [Pubmed]
  25. Reduced serotonin and 3-hydroxyanthranilic acid levels in serum of cystatin B-deficient mice, a model system for progressive myoclonus epilepsy. Arbatova, J., D'Amato, E., Vaarmann, A., Zharkovsky, A., Reeben, M. Epilepsia (2005) [Pubmed]
  26. Rat 3-hydroxyanthranilic acid oxygenase: purification from the liver and immunocytochemical localization in the brain. Okuno, E., Köhler, C., Schwarcz, R. J. Neurochem. (1987) [Pubmed]
  27. High-performance liquid chromatographic assay of human lymphocyte kynureninase activity levels. Ubbink, J.B., Vermaak, W.J., Bissbort, S.H. J. Chromatogr. (1991) [Pubmed]
  28. Influence of tryptophan loading on urinary excretion of anthranilic acid and 3-hydroxyanthranilic acid by men and women as determined by alkali flame ionization gas chromatography. van der Poll, J.M., Vink, M., Schrijver, J., Odink, J. J. Chromatogr. (1986) [Pubmed]
  29. 4-Chloro-3-hydroxyanthranilate inhibits quinolinate production in the rat hippocampus in vivo. Walsh, J.L., Wu, H.Q., Ungerstedt, U., Schwarcz, R. Brain Res. Bull. (1994) [Pubmed]
WikiGenes - Universities